A case of delayed-onset Stevens-Johnson syndrome following co-amoxiclav administration in a 98-year-old female
{{output}}
BackgroundStevens-Johnson Syndrome is a type IV hypersensitivity mucocutaneous reaction characterised by a widespread desquamating rash, and is considered to be an emergency due to its potentially fatal complications. Drugs account for 50-80% of Stevens-Jonson... ...
